Depakote ER

This page contains recent news articles, when available, and an overview of Depakote ER but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.


Overview:

Depakote ER
(when available)

Pharmacology and use:
Divalproex is an anticonvulsant and mood-stabilizing drug used primarily in the treatment of epilepsy and bipolar disorder. It is also used to treat migraine headaches and schizophrenia. In epileptics, Divalproex is used to control absence seizures, tonic-clonic seizures (grand mal), complex partial seizures, and the seizures associated with Lennox-Gastaut syndrome. Divalproex is believed to affect the function of the neurotransmitter GABA (as a GABA transaminase inhibitor) in the human brain. Divalproex dissociates to the valproate ion in the gastrointestinal tract. For treatment and management of Seizure disorders; Mania and Prophylactic treatment of migraine headache

Mechanism Of Action:
Divalproex binds to and inhibits GABA transaminase. The drug's anticonvulsant activity may be related to increased brain concentrations of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter in the CNS, by inhibiting enzymes that catabolize GABA or block the reuptake of GABA into glia and nerve endings. Divalproex may also work by suppressing repetitive neuronal firing through inhibition of voltage-sensitive sodium channels.

News Articles on Divalproex

FDA, Manufacturers Advise Physicians of Actions Involving Various Drugs  -  ‎Dec 11, 2009‎
...(Depacon) and related products, such as valproic acid (Depakene and Stavzor) and divalproex sodium (Depakote, Depakote CP and Depakote ER), in utero. ... AAFP News Now

Mylan Swings To 3Q Loss On Charges; Ups 2009 View  -  ‎Oct 29, 2009‎
...were impressive as they didn't include a substantial contribution from a generic version of Abbott Laboratories' (ABT) anti-epilepsy drug Depakote ER. ... Wall Street Journal

Mylan to launch generic of Abbott's Depakote ER  -  Jun 5, 2008
NEW YORK, June 5 (Reuters) - Mylan Inc MYL.N said on Thursday it settled patent litigation with Abbott Laboratories Inc (ABT.N) over Abbott's Depakote ER ... Reuters

Abbott's Depakote ER (Divalproex Sodium Extended-Release Tablets) …  -  Dec 6, 2005
ABBOTT PARK, IL -- December 6, 2005 -- Abbott announced that the US Food and Drug Administration (FDA) has approved a new indication for Depakote® ER ... DG News

Depakote(R) ER Approved For Acute Manic Or Mixed Episodes …  -  Dec 12, 2005
Depakote ER offers patients the convenience of taking this medication once a ... "Depakote ER produces consistent concentrations of medication throughout a ... Medical News Today - Medical News Today (press release)

IMPAX Announces Lawsuit Related to Generic Version of Depakote ER  -  Jun 19, 2007
IMPAX Laboratories, Inc. (OTC:IPXL) today announced that Abbott Laboratories has filed a lawsuit against the Company in the United States District Court for ... Genetic Engineering News - Genetic Engineering News (press release)

Article: Extended-release Depakote gets mania indication.(drug...  -  Jan 1, 2006
Article: FDA approval granted for once-daily Depakote ER. ... Administration (FDA) approval for Depakote ER for sole and adjunctive therapy to treat ... Pay-Per-View - Clinical Psychiatry News - HighBeam Research

Press Release: Abbott's Depakote(R) ER (Divalproex Sodium Extended- …  -  Dec 7, 2005
Depakote ER offers patients the convenience of taking this medication once a ... "Depakote ER produces consistent concentrations of medication throughout a ... Pay-Per-View - PR Newswire - HighBeam Research

Prozac & Depakote ER for Bipolar? BPD? Quitting Effexor XR.  -  May 9, 2007
Hello again. I have been here a lot in the past few weeks as I've been trying to find that magic combo to help me with my Bipolar I (Mixed, ... HealthCentral.com

FDA approved divalproex extended-release tablets (Depakote ER, Abbott...  -  Jan 1, 2006
FDA approved divalproex extended-release tablets (Depakote ER, Abbott). FDA approved divalproex extended-release tablets (Depakote ER, Abbott) for the ... $9.94 - Formulary - Alacra Store

FDA Approvals: Angiomax, Depakote ER, Hylenex  -  Dec 8, 2005
Dec. 8, 2005 — The US Food and Drug Administration (FDA) has approved bivalirudin injection for use in patients with or at risk of heparin-induced ... Medscape

Stakeholder backs Esmark deal  -  Jun 6, 2008
The agreement also provides for a license for Depakote ER in the 250-milligram strength. The drug is used in the treatment of bipolar disorder and epilepsy. ... Pittsburgh Post-Gazette - Pittsburgh Post Gazette

Article: Local Focus.(Business) - Daily Herald (Arlington Heights,...  -  Dec 8, 2005
Abbott said Depakote ER provides more consistent levels of medication in the body. ... Article: FDA approval granted for once-daily Depakote ER. ... Pay-Per-View - Daily Herald - HighBeam Research

ELSEWHERE IN THE MIDWEST  -  Jun 6, 2008
The deal also provides for a license for Depakote ER in the 250-milligram strength. PrivateBancorp Inc.: The Chicago bank holding company said Thursday that ... Pay-Per-View - Chicago Tribune - ProQuest Archiver

Mylan gets tentative OK for generic anti-seizure med  -  Mar 14, 2007
Depakote ER had US sales of roughly $698 million for similar-strength tablets for the 12-month period ending Dec. 31, according to IMS Health, a Fairfield, ... Bizjournals.com

Press Release: Etymotic Research, Inc. Receives 'Best Headphones of …  -  Nov 7, 2005
Depakote ER offers patients the convenience of taking ... sodium ... Depakote ER is the once-daily formulation of Depakote ... its initial approval in 1983. ... Pay-Per-View - PR Newswire - HighBeam Research

ELSEWHERE IN THE MIDWEST  -  May 23, 2008
...maker of drugs and medical devices settled a lawsuit with India's Wockhardt Ltd. over a generic form of its epilepsy treatment Depakote ER. ... Pay-Per-View - Chicago Tribune - ProQuest Archiver

Extended-release Depakote gets mania indication.(drug approval)(Brief...  -  Jan 1, 2006
Depakote ER (divalproex sodium extended-release), taken once a day, offers more consistent levels of medication in the body, and is more convenient, ... Free with registration - Clinical Psychiatry News - AccessMyLibrary.com

FDA expands indiction of Abbott's Depakote ER.(Food and Drug …  -  Dec 12, 2005
The US Food and Drug Administration has approved a new indication for US health care major Abbott Laboratories' Depakote ER (divalproex sodium ... $4.95 - Pharma Marketletter - ECNext

Article: OF NOTE - The Washington Post | HighBeam Research - FREE …  -  May 18, 2006
Article: FDA expands indiction of Abbott's Depakote ER.(Food and ... Pharma Marketletter; December 12, 2005 ; 700+ words . ... Pay-Per-View - Washington Post - HighBeam Research

A look at delayed--vs. extended-release Rxs.(FDA SAFETY PAGE)  -  Jul 23, 2007
Thus, when a patient was admitted taking Depakote ER 750 mg twice a day for ... Pharmacokinetic studies have shown that when Depakote ER is given in equal ... $4.95 - Drug Topics - ECNext

Delayed-release drug not enteric-coated.(Letters)(Letter to the...  -  Sep 17, 2007
Although the delayed-release Depakote formulation is an enteric-coated product, Depakote ER is not. Depakote ER features a hydrophilic polymer matrix system ... $4.95 - Drug Topics - ECNext

Noven Announces Final FDA Approval of Stavzor(TM) for the Treatment...  -  Jul 30, 2008
Depakote(R) and Depakote ER(R) are registered trademarks of Abbott Laboratories. Noven Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged ... Genetic Engineering News - Genetic Engineering News (press release)

Namenda for Migraine and Chronic Headache Prevention  -  Nov 3, 2007
Since I have migraines, too (and take Depakote ER), I know now that there is yet ... that I can try if Depakote ER becomes intolerable like Topamax did ... HealthCentral.com

Article: Bipolar drugs may raise risk of osteoporosis.(Adult Psychiatr...  -  Feb 1, 2005
Clinical Psychiatry News; January 1, 2006 ; 700+ words ... ... last month approved a new indication for Depakote ER for the treatment of acute mania or ... Pay-Per-View - Clinical Psychiatry News - HighBeam Research

Loislaw Federal District Court Opinions - COOK v. ASTRUE (NDTex. 10-2...  -  Oct 2, 2008
...fn2] Dr. Smith prescribed Depakote ER 500 mg. (Tr. 183, 189, 191-92. ... Cook stated that he "currently takes Depakote ER," 500 mg daily. (Tr. 160-61. ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw

Auburn faculty aims to clarify role.  -  Apr 23, 2007
The second significant error was for a Depakote ER prescription that was dispensed without a childproof cap. The third was on a label for Novolog Mix 70/30 ... $9.94 - Chain Drug Review - Alacra Store

FDA Warns Epilepsy Drugs May Raise Suicide Risk  -  Feb 1, 2008
Topiramate (marketed as Topamax), Valproate (marketed as Depakote, Depakote ER, Depakene, Depacon) and Zonisamide (marketed as Zonegran). ... Washington Post

Factiva Search  -  Dec 7, 2005
Abbott's Depakote ER (divalproex sodium extended-release tablets) approved for acute manic or mixed episodes associated with bipolar disorder. ... Pay-Per-View - Company Reports - Factiva, from Dow Jones

Article: European Union.(Region Watch)(Brief Article) - Instrument …  -  Feb 15, 2005
U.S. Food and Drug Administration (FDA) approval for Depakote ER for sole and ... Abbott also announced that the FDA has approved Depakote ER (divalproex . ... Pay-Per-View - Instrument Business Outlook - HighBeam Research

FDA Adds Suicide Warning to Epilepsy Drugs  -  Dec 15, 2008
Tegretol, Tegretol XR); clorazepate (Tranxene); divalproex sodium (Depakote, Depakote ER, Depakene); ethosuximide (Zarontin); ethotoin (Peganone); ... Forbes

FDA Advisers Don't Back 'Black Box' Warning for Epilepsy Drugs  -  Jul 10, 2008
Topiramate (marketed as Topamax), Valproate (marketed as Depakote, Depakote ER, Depakene, Depacon) and Zonisamide (marketed as Zonegran). ... Washington Post

Divalproex ER for acute mania.(What's New In Research)  -  Jan 1, 2007
...safety of divalproex sodium extended release (divalproex ER) (Depakote ER) in patients hospitalized for acute mania associated with bipolar I disorder. ... Free with registration - Brown University Psychopharmacology... - AccessMyLibrary.com

Once-Daily Divalproex Similar to Twice-Daily Formulations in Seizure ...  -  Dec 8, 2006
...[Presentation title: Prospective Evaluation of Seizure Frequency and Side Effect Profile When Switching Adult Patients From Depakote (DR to Depakote ER at a ... DG News

Abbott sues Wockhardt to block generic Depakote  -  May 16, 2007
...drugs and medical devices, sued India's Wockhardt Ltd. to block regulatory approval of a generic form of the company's epilepsy treatment, Depakote ER. ... Livemint

Medications for Preventing Migraine Attacks  -  Sep 9, 2008
A once-a-day formulation of divalproex (Depakote ER) was approved in 2000. Doctors sometimes prescribe a similar drug, valproate (Depakene). ... New York Times

PRESS DIGEST - Indian Business News - July 18  -  Jul 18, 2008
BO: Quote, Profile, Research) in a US court for infringing the patent of Depakote ER, an anti-seizure drug. * Germany's car maker BMW (BMWG. ... Reuters India

Suits aim to block generic epilepsy drug  -  Nov 22, 2005
Abbott Laboratories has filed lawsuits to block Mylan Laboratories Inc. from selling a generic version of the epilepsy drug Depakote ER in the U.S. ... Pay-Per-View - Chicago Tribune - ProQuest Archiver

Valproic acid for epilepsy  -  Oct 29, 2007
A newly approved, once-daily dose of divalproex sodium is also available (Depakote ER). Divalproex sodium and valproic acid are available as capsules and ... WebMD

Depakote cleared.(FDA approval for antipsychotic drug)(Brief Article)  -  Jan 16, 2006
Abbott Laboratories has received FDA approval to market Depakote ER for acute manic or mixed episodes associated with bipolar disorder. ... Free with registration - Chain Drug Review - AccessMyLibrary.com

FDA requires suicide warning on some drugs  -  Dec 17, 2008
Included among the anti-epileptic medications are the brand names Carbatrol, Equetro, Tegretol, Tegretol XR, Klonopin, Tranxene, Depakote, Depakote ER, ... Money Times - The Money Times

Air France-KLM, Carlsberg, Roche, UBS: European Equity Preview  -  Dec 9, 2007
Novartis AG (NOVN VX): Abbott Laboratories sued Novartis AG's Sandoz to prevent it from selling generic versions of the epilepsy drug Depakote ER in the US ... Bloomberg

United States 7th Circuit Court of Appeals Reports - BOILES v. …  -  Jan 20, 2005
He prescribed Depakote ER "as a seizure medication." In October 2001 Dr. Wallack saw Boiles again and noted that she reported only four daytime incidents in ... Pay-Per-View - United States 7th Circuit Court of... - Loislaw

Indian pharma prefers non-litigation route in US  -  Nov 22, 2007
Wockhardt, along with Teva and Impax, is among the contenders for Abbott's Depakote ER (Divalproex Sodium), a $430 million (US sales) drug for epileptic ... Rediff

Event Brief of Q2 2006 Abbott Laboratories Earnings Conference Call -...  -  Jul 19, 2006
4. Depakote sales growth in 2Q06 was up double digits. 1. Depakote ER, the Co.'s once-a-day version of Depakote, now accounts for approx. 50% of total Depakote. Free with registration - America's Intelligence Wire - AccessMyLibrary.com

Event Brief of Q3 2006 Abbott Laboratories Earnings Conference Call -...  -  Oct 1, 2006
Depakote ER accounts for roughly 50% of total Depakote prescriptions. 9. US Synthroid sales were $130m, up nearly 10%. 10. Anesthesia: 1. ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com

Top 200 brand-name drugs by units in 2005.(rankings )  -  Mar 20, 2006
Levothroid 3450 -18.0 97 Tussionex 3306 21.4 98 Endocet 3259 -39.2 99 Zyrtec-D 3201 -3.0 100 Depakote ER 3200 6.3 101 Humulin N 3190 -15.9 102 Budeprion ... Free with registration - Drug Topics - AccessMyLibrary.com

Wire Business Briefs - 12/08 | Business | PE.com | Southern California...  -  Dec 7, 2007
...sued Novartis AG's Sandoz and Cadila Healthcare Ltd.'s Zydus to prevent them from selling generic versions of the epilepsy drug Depakote ER in the US ... Press-Enterprise

US Bankruptcy Court Opinions - IN RE ROUSE (ND 9-5-2008)  -  Sep 5, 2008
He was treated for depression and prescribed Depakote ER, Wellbutrin SR and Serzone. His mood improved while on the medications and he was released on ... Pay-Per-View - U.S. Bankruptcy Court Opinions - Loislaw

Event Brief of Q3 2006 Abbott Laboratories Earnings Conference Call -...  -  Oct 18, 2006
Depakote ER accounts for roughly 50% of total Depakote prescriptions. 9. US Synthroid sales were $130m, up nearly 10%. 10. Anesthesia: 1. ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com

Article: Abbott sues Indian firm over patents - Chicago Sun-Times | …  -  May 16, 2007
Abbott Laboratories sued India's Wockhardt Ltd. to block regulatory approval of a generic form of the company's epilepsy treatment Depakote ER. ... Pay-Per-View - Chicago Sun-Times - HighBeam Research

United States top 200 brand and generic drugs used in hospitals in …  -  Jun 19, 2006
Casodex 135637734.50 1.56 154 Coumadin 135378423.52 -1.30 155 Norvir 132529813.80 6.33 156 Depakote ER 132344286.78 32.86 157 Valtrex 130200723.60 29.12 ... $20.00 - Drug Topics - Alacra Store

Daytona Beach News-Journal : In Brief  -  Sep 14, 2005
Other prescription drugs added include Depakote ER, Keppra, Lamictal, Trileptal and Zonegran. Eli Lilly, one of the nation's largest pharmaceutical ... $2.95 - Daytona Beach News-Journal - NewsBank

FDA Weighs Pros and Cons of Black Box Warning for Epilepsy Drugs  -  Jul 12, 2008
...topiramate (marketed as Topamax), valproate (marketed as Depakote, Depakote ER, Depakene, Depacon) and zonisamide (marketed as Zonegran). ... Daily News Central

Chicago Sun-Times : Abbott sues Indian firm over patents  -  May 16, 2007
Abbott Laboratories sued India's Wockhardt Ltd. to block regulatory approval of a generic form of the company's epilepsy treatment Depakote ER. ... $2.95 - Chicago Sun-Times - NewsBank

Depakote cleared.  -  Jan 16, 2006
Abbott Laboratories has received FDA approval to market Depakote ER for acute manic or mixed episodes associated with bipolar disorder. ... $9.94 - Chain Drug Review - Alacra Store

Six mental health drugs join Medicaid preferred-brands list  -  Sep 13, 2005
The other drugs added Monday are Depakote ER, Keppra, Lamictal, Trileptal and Zonegran. Officials at the Agency for Health Care Administration said they ... sptimes.com

Depakote cleared.(FDA approval for antipsychotic drug)(Brief Article)...  -  Jan 16, 2006
Abbott Laboratories has received FDA approval to market Depakote ER for acute manic or mixed episodes associa... Pay-Per-View - Chain Drug Review - HighBeam Research

ALSO NOTED: Salix licenses product; FDA OKs new Depakote indication; …  -  Dec 6, 2005
The FDA has approved a new indication for Depakote ER. Release. > A new report gives more than half of US states a failing grade for their ability to handle ... FierceBiotech

Pfizer shares droop on Goldman downgrade; Mylan, Abbott settle fight ...  -  Jun 5, 2008
Mylan and Abbott Laboratories have settled their patent fight over Depakote ER; the deal allows Mylan 180-day exclusivity on 500 mg tablets to be launched ... FiercePharma

Press Release: Mylan Announces Tentative FDA Approval for Divalproex ...  -  Mar 14, 2007
Divalproex Sodium ER Tablets are the generic version of Abbot Laboratories' Depakote ER(R) Tablets, which had U.S. sales of approximately $698 million for ... Pay-Per-View - PR Newswire - HighBeam Research

I am taking Clonazepam,Lithium,Depakote, Fluoxetine and zonisamide. I...  -  Jun 21, 2008
For the last 8 months I have been taking Depakote ER 500mg 2x daily (for headaches) and just recently started taking Fluoxetine 20mg 2x daily (for ... HealthCentral.com

Fla. Medicaid, Drug Firm Reach Deal on Antipsychotic Drug  -  Sep 17, 2005
Other drugs added to the preferred list in Monday's announcement were Depakote ER, Keppra, Lamictal, Trileptal and Zonegran, a variety of mental health ... RedOrbit

ALSO NOTED: Eisai inks $3.9B deal for MGI; Reckitt Benckiser buying …  -  Dec 10, 2007
Abbott Laboratories has sued two generics firms seeking approval to sell generic versions of the epilepsy drug Depakote ER. Sandoz and Cadila Healthcare say ... FiercePharma

Astonishing 52 Percent of Newly Diagnosed Bipolar Disorder Patients …  -  Aug 11, 2008
Lamictal and Abbott's Depakote ER are frequently prescribed first line by surveyed psychiatrists for bipolar disorder II patients who present with acute ... RedOrbit

STEPS - October 15, 2005 - - American Family Physician  -  Oct 15, 2005
A one-month supply (60 tablets) of 50-mg tablets will cost patients approximately $210, compared with $130 for 100 tablets of divalproex (Depakote ER) and ... AAFP News Now

"Old" Versus "New" Antiepileptic Drugs  -  Nov 1, 2005
These advances include an extended- release form of divalproex sodium (Depakote ER, Abbott) and a sprinkle form (Depakote Sprinkle Capsules, Abbott), ... Psychiatric Times

11/20/07 #3 - Hysterectomy, Migraines, chronic daily headaches?  -  Nov 20, 2007
Depakote ER did help, but I gained ~30 lbs and began loosing hair. Unable to take other neuroleptics because of side effects (I am a pharmacist, ... HealthCentral.com

Top 100 pharmaceutical products *.(RX/BRANDED DRUGS)(Statistical …  -  Apr 23, 2007
MSD Singulair $451001678.02 AstraZeneca Seroquel $450359039.19 GlaxoSmithKline Imitrex $446672468.43 Abbott Depakote ER $434929386.92 Pfizer US Pharm. ... Free with registration - Chain Drug Review - AccessMyLibrary.com

has anyone tried the new migraine medicine (supatripan and naproxen)?  -  May 19, 2008
Been put on Depakote ER as well today. We will see..... Yes and I found that niether combined or taken together help. Sorry ... HealthCentral.com

Top 200 brand-name drugs by retail dollars in 2006.(COMMUNITY …  -  Feb 19, 2007
512978 -44.0 76 Yesmin 28 508160 15.2 77 Evista 507954 0.6 78 CellCept 507652 9.9 79 Humira 505566 28.0 80 Depakote ER 501961 17.2 81 Keppra 498913 31.4 ... Free with registration - Drug Topics - AccessMyLibrary.com

Kaiser Daily Health Policy Report Highlights News Coverage of State …  -  Sep 16, 2005
...state Agency for Health Care Administration said newly negotiated discounts with manufacturers have allowed them to add Zyprexa, Depakote ER, Keppra, ... Medical News Today - Medical News Today (press release)

Top 75 Migraine and Headache Questions, #43  -  Apr 8, 2007
I developed menopausal migraines after my hysterectomy 1 year ago. I still have one ovary, but subsequent blood tests have shown me to be in menopause I ... HealthCentral.com

Global top 200 brand-name drugs ranked by retail sales in dollars and...  -  Feb 21, 2005
335038 2.3 84 Zithromax 330200 28.6 85 Avandamet 330146 192.8 86 Yasmin 28 327574 51.8 87 Depakote ER 326183 35.1 88 Avapro 323367 12.3 89 Asacol 322219 ... $20.00 - Drug Topics - Alacra Store

Tennessee Reports - SAYLOR v. LAKEWAY TRUCKING, INC., 181 SW3d …  -  Nov 29, 2005
Moreover, at the time of Dr. McKnight's deposition, Page 323 Saylor was taking Depakote ER to improve his sleeping and two antidepressants, Zoloft and Xanax ... Pay-Per-View - Tennessee Reports - Loislaw

United States top 200 brand-name drugs by retail sales in dollars and...  -  Mar 6, 2006
74 Hyzaar 448157 4.9 75 Skelaxin 445377 11.5 76 Yasmin 28 441299 34.7 77 Lovenox 438815 32.7 78 Prograf 431631 19.2 79 Depakote ER 428334 17.9 80 Ortho ... $20.00 - Drug Topics - Alacra Store

Press Release: PFIZER INC - Regulatory Approval. - PR Newswire UK …  -  Nov 1, 2005
...without ... serious illnesses, bipolar disorder can have a negative ... the acute manic and mixed episodes of bipolar disorder. Depakote ER in Acute ... ... Pay-Per-View - PR Newswire UK Disclose - HighBeam Research

Article: New-onset epilepsy mimics dementia in the elderly.(Neurology)...  -  Mar 15, 2005
Depakote ER is the ... children under age 18. Epilepsy is a chronic neurological ... range of patients with epilepsy," said Bill Dempsey ... for the ... Pay-Per-View - Internal Medicine News - HighBeam Research

Press Release: Pfizer's Zeldox Receives Approval in Europe to Treat …  -  Oct 31, 2005
...without ... serious illnesses, bipolar disorder can have a negative ... the acute manic and mixed episodes of bipolar disorder. Depakote ER in Acute ... ... Pay-Per-View - PR Newswire - HighBeam Research

Article: New-onset epilepsy can resemble dementia in some elderly …  -  Mar 1, 2005
Depakote ER is the ... children under age 18. Epilepsy is a chronic neurological ... range of patients with epilepsy," said Bill Dempsey ... for the ... Pay-Per-View - Family Practice News - HighBeam Research

Drugs, pregnancy, and lactation: valproic acid.(Obstetrics) | Article...  -  Mar 15, 2006
...valproic acid, and valproate sodium, marketed as Depakote tablets, Depakote ER tablets, Depakote sprinkle capsules, Depakene capsules ... ... Pay-Per-View - OB GYN News - HighBeam Research

FDA has issued an alert for the anti-epileptic drugs.  -  Mar 1, 2008
...tiagabine (Gabitril, Cephalon), topiramate (Topamax, Ortho-McNeil), valproate (Depakote, Depakote ER, Depakene, and Depacon, Abbott; generic valproate), ... $9.94 - Formulary - Alacra Store

FDA approves new indication for Abbott bi-polar drug  -  Dec 9, 2005
..."This expansion of the use of Depakote ER is another important step in Abbott's commitment to developing innovative, effective and simpler treatments for ... Pay-Per-View - Datamonitor News and Comment - Factiva, from Dow Jones

What's happening, at some of the key players.  -  May 1, 2006
In December 2005 the Food and Drug Administration approved a new indication for Depakote ER to treat acute manic or mixed episodes due to bipolar disorder. ... $20.00 - Chain Drug Review - Alacra Store

Article: FDA adds new indications for aripiprazole.(Adult Psychiatry)...  -  Jun 1, 2008
Clinical Psychiatry News; January 1, 2006 ; 700+ words ... ... approved a new indication for Depakote ER for the treatment of acute mania or mixed episodes ... Pay-Per-View - Clinical Psychiatry News - HighBeam Research

Epilepsy drug.(RXs)(Brief article) | Article from Chain Drug Review |...  -  Jan 21, 2008
Abbott Laboratories' once-daily Depakote ER has received approval for pediatric use. The epilepsy drug offers children 10 and older a convenient treatment ... Pay-Per-View - Chain Drug Review - HighBeam Research

Top 300 single-source brand drugs by manufacturer and NDC11 number. …  -  Apr 28, 2008
Effexor XR00008083622 56 AstraZeneca Nexium00186504054 57 Abbott Depakote ER 00074712613 58 AstraZeneca Seroquel 00310027110 59 Wyeth Pharm. ... Pay-Per-View - Chain Drug Review - HighBeam Research

ABBOTT LABORATORIES  -  Mar 1, 2008
Page IV-1. CAROTID STENTS - A GLOBAL STRATEGIC BUSINESS REPORT 03/08. © Global Industry Analysts, Inc., Phone: 408-528-9966, Fax: 408-528-9977 ... $3,450.00 - GLOBAL INDUSTRY ANALYSTS KEY PLAYERS - Alacra Store

Local Focus.(Business) | Article from Daily Herald (Arlington...  -  Nov 22, 2005
...based Mylan Laboratories Inc. from selling a generic version of the epilepsy drug Depakote ER in the U.S. Mylan, which originally said it didn't plan to ... Pay-Per-View - Daily Herald - HighBeam Research

Noven Gets Final FDA OK for Stavzor | Article from Wireless News | …  -  Aug 4, 2008
The Company noted Stavzor soft gel capsules are small (up to 40 percent smaller than Depakote and Depakote ER tablets at the 500 mg dosage strength) and ... Pay-Per-View - Wireless News - HighBeam Research

Top 200 drugs used in hospitals in 2006.(Table)  -  Apr 16, 2007
Amox TR-Potassium Clavulanate 53425201.64 11.01 163 TNKase 53205408.08 -6.39 164 Zetia 52823145.27 51.33 165 Depakote ER 52807153.98 47.95 166 Vancocin ... $4.95 - Drug Topics - ECNext

EBSCOhost Connection: News from the FDA.  -  Feb 1, 2006
Depakote ER or the divalproex, extended-release has received a new indication for the treatment of acute mania or mixed episodes associated with bipolar ... Subscription - Patient Care for the Nurse Practitioner - EBSCO Publishing

Camber debut.(Generic Drugs)(Hereto Drugs Ltd.'s zidovudine gets FDA ...  -  May 19, 2008
Abbott Laboratories has received FDA approval to market Depakote ER for acute manic or mixed episodes associated with bipolar disorder. ... Pay-Per-View - Chain Drug Review - HighBeam Research

New, easier-to-swallow capsule approved to treat bipolar disorder.  -  Sep 15, 2008
Delivered in soft-gel delayed-release capsules, the product is up to 40 percent smaller than Depakote and Depakote ER tablets at the 500 mg dosage. ... $9.94 - Drug Topics - Alacra Store

FDA has issued an alert for the anti-epileptic drugs.  -  Mar 1, 2008
...tiagabine (Gabitril, Cephalon), topiramate (Topamax, Ortho-McNeil), valproate (Depakote, Depakote ER, Depakene, and Depacon, Abbott; generic valproate), ... $9.94 - Formulary - Alacra Store

Nasacort gets nod.(RXs)(Sanofi-Aventis SA)(Brief article) | Article...  -  Oct 27, 2008
Abbott Laboratories' once-daily Depakote ER has received approval for pediatric use. The epilepsy drug offers children 10 and older a convenient treatment ... Pay-Per-View - Chain Drug Review - HighBeam Research

Top 200 brand-name drugs by retail dollars in 2006.(COMMUNITY …  -  Feb 19, 2007
512978 -44.0 76 Yesmin 28 508160 15.2 77 Evista 507954 0.6 78 CellCept 507652 9.9 79 Humira 505566 28.0 80 Depakote ER 501961 17.2 81 Keppra 498913 31.4 ... $4.95 - Drug Topics - ECNext

Top 200 brand name drugs by units in 2006.(COMMUNITY PRACTICE)( …  -  Mar 5, 2007
89 Patanol 3731 0.1 90 Depakote 3702 -9.2 91 Abilify 3691 21.0 92 Flonase 3668 -75.1 93 Avelox 3590 21.9 94 Humalog 3538 -2.0 95 Depakote ER 3508 9.6 96 ... $4.95 - Drug Topics - ECNext

Federal Register 2008 - 73 FR 32588 Joint Meeting of the Peripheral...  -  Jun 9, 2008
...(10) valproate (marketed as DEPAKOTE, DEPAKOTE ER, DEPAKENE, DEPACON, Abbott Laboratories); and (11) zonisamide (marketed as ZONEGRAN, Dainippon). ... Pay-Per-View - Federal Register 2008 - Loislaw

Factiva Search  -  Dec 12, 2005
FDA expands indiction of Abbott's Depakote ER.(Food and Drug Administration)(Abbott Laboratories Inc.)(Brief Article). 12 December, 2005 Pharma Marketletter ... Pay-Per-View - Pharma Marketletter - Factiva, from Dow Jones

Keppra.(New & Approved) | Article from Pediatric News | HighBeam …  -  Aug 1, 2005
Depakote, Depakote ER), felbamate (Felbatol), gabapentin (Neurontin), lamotrigine (Lamictal), levetiracetam (Keppra), oxcarbazepine (Trileptal), ... Pay-Per-View - Pediatric News - HighBeam Research

Article: Top 100 pharmaceutical products *.(RX/BRANDED DRUGS)( …  -  Apr 23, 2007
Depakote ER 00074712613 58 AstraZeneca Seroquel 00310027110 59 Wyeth Pharm. Effexor XR 00008083621 ... Chain Drug Review. Article: Top 75 single-source ... Pay-Per-View - Chain Drug Review - HighBeam Research

Brand Names/Synonyms:
Depakote ER is also known by the following brand names and/or synonymsAcetic Acid, Dipropyl-; Convulex; DPA; Depakene; Depakine; Depakote; Depakote Cp; Depakote Er; Depakote Sprinkle; Dipropylacetic Acid; Divalproex; Divalproex Sodium; Epilim; Epival; Ergenyl; Mylproin; N-Dipropylacetic Acid; N-Dpa; Propylvaleric Acid; SEMISODIUM VALPROATE; Valproate Semisodium; Valproic Acid; Valproic Acid Usp; Valproic Acid Usp24

Drug Category:
Depakote ER is categorized under the following by the FDA: Antimanic Agents; GABA Agents; Anticonvulsants; ATC:N03AG

Dosage Forms:
TABLET (ENTERIC-COATED)

Absorption:
Not Available

Interactions:
[an error occurred while processing this directive]



Chemical IUPAC Name:
sodium; 2-propylpentanoate; 2-propylpentanoic acid





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy